Chronic widespread pain affects millions of adults and remains stubbornly resistant to treatment, making every well-designed trial worth scrutiny. The prevailing hypothesis — that targeting both the psychological stress response and physical deconditioning simultaneously could produce synergistic relief — seemed clinically compelling. This trial puts that hypothesis to a rigorous test, and the answer is a cautionary null result.
The Swedish multicenter RCT enrolled 129 adults aged 18–70 with chronic widespread pain, randomly assigning them to either a 14-module therapist-guided internet-based cognitive behavioral therapy (iCBT) program combined with a physiotherapist-guided physical activity plan, or to physical activity alone. Over six months, researchers tracked pain intensity, number of pain locations, stress, fatigue, depression, and quality of life via self-reported questionnaires. At follow-up, no statistically significant between-group differences emerged on any primary or secondary outcome. Critically, adherence was poor: only 37% of the iCBT group completed all 14 modules, and just 64% of participants overall provided six-month data.
This result sits within a broader landscape of mixed evidence for iCBT in musculoskeletal and pain conditions. While iCBT has demonstrated efficacy for anxiety, depression, and insomnia in adequately powered trials, its translation to chronic pain — particularly widespread, centrally sensitized pain — has been inconsistent. The null finding here likely reflects two compounding problems: insufficient adherence to the digital intervention and possible underpowering given the 36% dropout rate. A sample of 129 is modest for detecting small-to-moderate effects in heterogeneous chronic pain populations. The study also relied entirely on self-report and was unblinded, introducing potential response bias in both directions. Rather than disproving the dual-mechanism hypothesis, this trial underscores that digital therapeutic delivery must solve the engagement problem before effectiveness can be fairly evaluated. Future research should prioritize adherence-optimized delivery and larger samples before concluding combination approaches offer no advantage.